NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that Company management will participate at the following investor conferences in September: 17th Annual Rodman & Renshaw Global Investment Conference being held from September 8-10, 2015 at the St. Regis Hotel in New York City. Gil Efron, Kamada’s Deputy CEO & Chief Financial Officer, will present a corporate overview and upd
| < Prev | Next > |
|---|
